Grupo 16B: Fisiopatología del sistema cardiovascular y soporte circulatorio
Código de grupo: 7.16B
Tipo de grupo: Emergente
Descripción del grupo: Fisiopatología del sistema cardiovascular y soporte circulatorio
Jefe de Grupo: Mª Begoña Quintana Villamandos y Juan Francisco del Cañizo
Integrantes del grupo | |
---|---|
Investigadores y personal de apoyo |
ARNALICH | MONTIEL | ANA | Recognised Researcher |
ARRIBAS | RODRIGUEZ | SILVIA MAGDALENA | Established Researcher |
BARRIO | GUTIERREZ | JOSE MARIA | Recognised Researcher |
BENEYTO | CRUZ | ROSARIO | |
CUERPO | CABALLERO | GREGORIO PABLO | Recognised Researcher |
DEL CAÑIZO | LOPEZ | JUAN FRANCISCO | Leading Researcher |
DELGADO | BAEZA | EMILIO | Established Researcher |
DELGADO | MARTOS | MARIA JESUS | Recognised Researcher |
FERNANDEZ | LOPEZ | IGNACIO | First Stage Researcher |
HERRERO | DE LA PARTE | BORJA | Recognised Researcher |
IGLESIAS | DE LA VEGA | MARIO | Recognised Researcher |
MARTIN | OROPESA | RAQUEL | Recognised Researcher |
MORILLAS | SENDÍN | PALOMA | Recognised Researcher |
PAZO | SAYOS | LAIA | Recognised Researcher |
QUINTANA | VILLAMANDOS | MARIA BEGOÑA | Leading Researcher |
RUIZ | FERNANDEZ | MANUEL | Recognised Researcher |
VEGA | SANCHEZ | VICTORIA EUGENIA | First Stage Researcher |
Líneas de investigación | |
---|---|
Axis 1: Ventricular remodelling
L1: Immunohistopathology and ultrastructure of ventricular remodelling L2: Pathophysiology of ventricular remodelling L3: Serum biomarkers of cardiac pathology L4: New therapies in the regression of ventricular remodelling Axis 2: Vascular remodelling L1: Foetal origin of cardiovascular disease and nutrition L2: Structure and function in vascular remodelling L3: Serum biomarkers of vascular pathology L4: New therapies in the regression of vascular remodelling Axis 3: Mechanical circulatory support L1: Anaesthetic drugs and organ perfusion in mechanical circulatory support (MCA) L2: Advances in haemodynamic monitoring in MCA L3: Cardiovascular physiopathology and MCA L4: Pulsatile vs. continuous flow in MCA Axis 4: Hepatic physiopathology L1: Decellularisation of the liver L2: Normothermic perfusion of isolated liver Axis 5: 3D printing L1: 3D skin printing |
First decile publications | 2 | 11,3 |
First quartile publications | 5 | 25,8 |
Second quartile publications | 4 | 16,2 |
Third quartile publications | 1 | 2,4 |
Total publications (including those without IF) | 17 | 46,2 |